Article
REBASTINIB, OLVEREMBATINIB, AND NAS-181 INHIBIT <i>MYCOBACTERIUM ABSCESSUS</i> BY DISRUPTING MYCOTHIOL HOMEOSTASIS
2025-08-23
Abstract excerpt
<h4>ABSTRACT</h4> Nontuberculous mycobacteria (NTM), particularly Mycobacterium abscessus , pose a major clinical challenge due to intrinsic drug resistance and limited therapeutic options. In this study, we evaluated three repurposed kinase inhibitors, such as rebastinib, olverembatinib, and NAS-181for their antimycobacterial potential against M. abscessus . All three compounds displayed measurable in vitro ac...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 46b74213-8712-5484-9e29-02e4e5d86afa
- DOI
- 10.1101/2025.08.22.671851
